nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—Cytochrome P450 2D6 Inhibitors—Clobazam—epilepsy syndrome	0.247	0.697	CiPCiCtD
Ranolazine—SCN9A—epilepsy syndrome	0.156	0.865	CbGaD
Ranolazine—Methocarbamol—Felbamate—epilepsy syndrome	0.138	1	CrCrCtD
Ranolazine—P-Glycoprotein Inhibitors—Zonisamide—epilepsy syndrome	0.108	0.303	CiPCiCtD
Ranolazine—CYP2D6—epilepsy syndrome	0.0244	0.135	CbGaD
Ranolazine—SCN9A—Lacosamide—epilepsy syndrome	0.0237	0.099	CbGbCtD
Ranolazine—SCN9A—Lamotrigine—epilepsy syndrome	0.0237	0.099	CbGbCtD
Ranolazine—SCN9A—Rufinamide—epilepsy syndrome	0.021	0.0874	CbGbCtD
Ranolazine—SCN9A—Carbamazepine—epilepsy syndrome	0.0204	0.0852	CbGbCtD
Ranolazine—SCN9A—Phenytoin—epilepsy syndrome	0.0183	0.0764	CbGbCtD
Ranolazine—SCN5A—Oxcarbazepine—epilepsy syndrome	0.0175	0.0728	CbGbCtD
Ranolazine—SCN5A—Fosphenytoin—epilepsy syndrome	0.0153	0.0637	CbGbCtD
Ranolazine—SCN9A—Zonisamide—epilepsy syndrome	0.0151	0.063	CbGbCtD
Ranolazine—SCN5A—Lamotrigine—epilepsy syndrome	0.0127	0.0531	CbGbCtD
Ranolazine—SCN5A—Rufinamide—epilepsy syndrome	0.0113	0.0469	CbGbCtD
Ranolazine—SCN5A—Carbamazepine—epilepsy syndrome	0.011	0.0457	CbGbCtD
Ranolazine—SCN5A—Phenytoin—epilepsy syndrome	0.00984	0.041	CbGbCtD
Ranolazine—SCN5A—Zonisamide—epilepsy syndrome	0.00811	0.0338	CbGbCtD
Ranolazine—SCN5A—Topiramate—epilepsy syndrome	0.00591	0.0247	CbGbCtD
Ranolazine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00212	0.00885	CbGbCtD
Ranolazine—CYP3A4—Felbamate—epilepsy syndrome	0.00197	0.00823	CbGbCtD
Ranolazine—CYP3A4—Trimethadione—epilepsy syndrome	0.00197	0.00823	CbGbCtD
Ranolazine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00185	0.00773	CbGbCtD
Ranolazine—CYP2D6—Propofol—epilepsy syndrome	0.00175	0.00731	CbGbCtD
Ranolazine—CYP3A4—Clonazepam—epilepsy syndrome	0.00168	0.00699	CbGbCtD
Ranolazine—CYP3A4—Clobazam—epilepsy syndrome	0.00161	0.00671	CbGbCtD
Ranolazine—CYP3A4—Rufinamide—epilepsy syndrome	0.00137	0.0057	CbGbCtD
Ranolazine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00133	0.00556	CbGbCtD
Ranolazine—CYP3A4—Primidone—epilepsy syndrome	0.00124	0.00519	CbGbCtD
Ranolazine—CYP3A4—Phenytoin—epilepsy syndrome	0.00119	0.00498	CbGbCtD
Ranolazine—CYP3A4—Propofol—epilepsy syndrome	0.00111	0.00465	CbGbCtD
Ranolazine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00106	0.00444	CbGbCtD
Ranolazine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00106	0.00444	CbGbCtD
Ranolazine—CYP3A4—Midazolam—epilepsy syndrome	0.00105	0.00438	CbGbCtD
Ranolazine—CYP3A4—Diazepam—epilepsy syndrome	0.00101	0.00421	CbGbCtD
Ranolazine—CYP3A4—Zonisamide—epilepsy syndrome	0.000985	0.00411	CbGbCtD
Ranolazine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000796	0.00332	CbGbCtD
Ranolazine—CYP3A4—Topiramate—epilepsy syndrome	0.000718	0.003	CbGbCtD
Ranolazine—Levobupivacaine—SCN4A—epilepsy syndrome	0.000253	0.152	CrCbGaD
Ranolazine—Ropivacaine—SCN8A—epilepsy syndrome	0.00022	0.131	CrCbGaD
Ranolazine—Bupivacaine—SCN4A—epilepsy syndrome	0.000203	0.121	CrCbGaD
Ranolazine—Ropivacaine—SCN9A—epilepsy syndrome	0.000178	0.106	CrCbGaD
Ranolazine—Ropivacaine—SCN3A—epilepsy syndrome	0.00017	0.102	CrCbGaD
Ranolazine—Ropivacaine—SCN4A—epilepsy syndrome	0.000163	0.0977	CrCbGaD
Ranolazine—Ropivacaine—SCN1A—epilepsy syndrome	0.000119	0.0714	CrCbGaD
Ranolazine—Ropivacaine—SCN2A—epilepsy syndrome	0.000105	0.063	CrCbGaD
Ranolazine—Carvedilol—VEGFA—epilepsy syndrome	4.83e-05	0.0289	CrCbGaD
Ranolazine—Bupivacaine—CYP2C19—epilepsy syndrome	4.65e-05	0.0278	CrCbGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	3.63e-05	0.00141	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—GDNF—epilepsy syndrome	3.6e-05	0.0014	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TH—epilepsy syndrome	3.49e-05	0.00135	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—SPTAN1—epilepsy syndrome	3.49e-05	0.00135	CbGpPWpGaD
Ranolazine—Bupivacaine—CYP2D6—epilepsy syndrome	3.45e-05	0.0206	CrCbGaD
Ranolazine—SCN5A—Developmental Biology—SCN2A—epilepsy syndrome	3.39e-05	0.00131	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CACNA1G—epilepsy syndrome	3.39e-05	0.00131	CbGpPWpGaD
Ranolazine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	3.35e-05	0.0013	CbGpPWpGaD
Ranolazine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	3.34e-05	0.0013	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	3.33e-05	0.00129	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TCF4—epilepsy syndrome	3.3e-05	0.00128	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—DLG4—epilepsy syndrome	3.24e-05	0.00126	CbGpPWpGaD
Ranolazine—Carvedilol—ADRA2A—epilepsy syndrome	3.24e-05	0.0194	CrCbGaD
Ranolazine—SCN9A—Axon guidance—GRIN2B—epilepsy syndrome	3.17e-05	0.00123	CbGpPWpGaD
Ranolazine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	3.15e-05	0.00122	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PRNP—epilepsy syndrome	3.13e-05	0.00121	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CDH2—epilepsy syndrome	2.94e-05	0.00114	CbGpPWpGaD
Ranolazine—SCN9A—L1CAM interactions—SRC—epilepsy syndrome	2.93e-05	0.00114	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	2.92e-05	0.00113	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	2.9e-05	0.00112	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	2.89e-05	0.00112	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CNTN2—epilepsy syndrome	2.88e-05	0.00112	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	2.88e-05	0.00112	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	2.86e-05	0.00111	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—ADAM10—epilepsy syndrome	2.85e-05	0.00111	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	2.84e-05	0.0011	CbGpPWpGaD
Ranolazine—Ropivacaine—CYP2D6—epilepsy syndrome	2.78e-05	0.0166	CrCbGaD
Ranolazine—SCN5A—Developmental Biology—ANK3—epilepsy syndrome	2.76e-05	0.00107	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—SLIT2—epilepsy syndrome	2.76e-05	0.00107	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ACTB—epilepsy syndrome	2.75e-05	0.00107	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	2.73e-05	0.00106	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—PRNP—epilepsy syndrome	2.73e-05	0.00106	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ITGA2—epilepsy syndrome	2.7e-05	0.00105	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—APOE—epilepsy syndrome	2.67e-05	0.00104	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—CDC42—epilepsy syndrome	2.67e-05	0.00103	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CACNA1D—epilepsy syndrome	2.66e-05	0.00103	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	2.64e-05	0.00102	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—GDNF—epilepsy syndrome	2.57e-05	0.000996	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	2.55e-05	0.000989	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	2.52e-05	0.000978	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	2.51e-05	0.000973	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—SPTAN1—epilepsy syndrome	2.49e-05	0.000965	CbGpPWpGaD
Ranolazine—Abdominal pain—Carbamazepine—epilepsy syndrome	2.47e-05	0.000411	CcSEcCtD
Ranolazine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	2.47e-05	0.000411	CcSEcCtD
Ranolazine—Rash—Levetiracetam—epilepsy syndrome	2.46e-05	0.000409	CcSEcCtD
Ranolazine—Dermatitis—Levetiracetam—epilepsy syndrome	2.46e-05	0.000408	CcSEcCtD
Ranolazine—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	2.46e-05	0.000953	CbGpPWpGaD
Ranolazine—Asthenia—Zonisamide—epilepsy syndrome	2.46e-05	0.000408	CcSEcCtD
Ranolazine—Mental disorder—Gabapentin—epilepsy syndrome	2.46e-05	0.000408	CcSEcCtD
Ranolazine—Dry mouth—Valproic Acid—epilepsy syndrome	2.45e-05	0.000407	CcSEcCtD
Ranolazine—Headache—Levetiracetam—epilepsy syndrome	2.44e-05	0.000406	CcSEcCtD
Ranolazine—Malnutrition—Gabapentin—epilepsy syndrome	2.44e-05	0.000406	CcSEcCtD
Ranolazine—Angioedema—Pregabalin—epilepsy syndrome	2.43e-05	0.000404	CcSEcCtD
Ranolazine—Dizziness—Vigabatrin—epilepsy syndrome	2.43e-05	0.000403	CcSEcCtD
Ranolazine—Confusional state—Valproic Acid—epilepsy syndrome	2.42e-05	0.000403	CcSEcCtD
Ranolazine—Pruritus—Zonisamide—epilepsy syndrome	2.42e-05	0.000403	CcSEcCtD
Ranolazine—Flatulence—Gabapentin—epilepsy syndrome	2.4e-05	0.0004	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—ACTB—epilepsy syndrome	2.4e-05	0.000931	CbGpPWpGaD
Ranolazine—Urticaria—Lamotrigine—epilepsy syndrome	2.4e-05	0.000399	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	2.4e-05	0.000931	CbGpPWpGaD
Ranolazine—Bradycardia—Topiramate—epilepsy syndrome	2.4e-05	0.000399	CcSEcCtD
Ranolazine—Nausea—Propofol—epilepsy syndrome	2.4e-05	0.000399	CcSEcCtD
Ranolazine—Vomiting—Fosphenytoin—epilepsy syndrome	2.39e-05	0.000398	CcSEcCtD
Ranolazine—Vertigo—Pregabalin—epilepsy syndrome	2.39e-05	0.000397	CcSEcCtD
Ranolazine—Abdominal pain—Lamotrigine—epilepsy syndrome	2.39e-05	0.000397	CcSEcCtD
Ranolazine—Dizziness—Diazepam—epilepsy syndrome	2.39e-05	0.000397	CcSEcCtD
Ranolazine—Syncope—Pregabalin—epilepsy syndrome	2.39e-05	0.000397	CcSEcCtD
Ranolazine—Leukopenia—Pregabalin—epilepsy syndrome	2.38e-05	0.000396	CcSEcCtD
Ranolazine—Rash—Fosphenytoin—epilepsy syndrome	2.37e-05	0.000395	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—FYN—epilepsy syndrome	2.37e-05	0.00092	CbGpPWpGaD
Ranolazine—Dermatitis—Fosphenytoin—epilepsy syndrome	2.37e-05	0.000394	CcSEcCtD
Ranolazine—Asthenia—Clonazepam—epilepsy syndrome	2.37e-05	0.000393	CcSEcCtD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	2.37e-05	0.000918	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ITGA2—epilepsy syndrome	2.36e-05	0.000915	CbGpPWpGaD
Ranolazine—Headache—Fosphenytoin—epilepsy syndrome	2.36e-05	0.000392	CcSEcCtD
Ranolazine—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.36e-05	0.000392	CcSEcCtD
Ranolazine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.35e-05	0.000391	CcSEcCtD
Ranolazine—Palpitations—Pregabalin—epilepsy syndrome	2.35e-05	0.000391	CcSEcCtD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	2.35e-05	0.000912	CbGpPWpGaD
Ranolazine—Asthenia—Phenytoin—epilepsy syndrome	2.35e-05	0.000391	CcSEcCtD
Ranolazine—Nausea—Midazolam—epilepsy syndrome	2.35e-05	0.00039	CcSEcCtD
Ranolazine—Hypoaesthesia—Topiramate—epilepsy syndrome	2.35e-05	0.00039	CcSEcCtD
Ranolazine—Hallucination—Topiramate—epilepsy syndrome	2.35e-05	0.00039	CcSEcCtD
Ranolazine—Muscle spasms—Gabapentin—epilepsy syndrome	2.35e-05	0.00039	CcSEcCtD
Ranolazine—Loss of consciousness—Pregabalin—epilepsy syndrome	2.34e-05	0.000389	CcSEcCtD
Ranolazine—Asthenia—Oxcarbazepine—epilepsy syndrome	2.34e-05	0.000389	CcSEcCtD
Ranolazine—Pruritus—Clonazepam—epilepsy syndrome	2.33e-05	0.000388	CcSEcCtD
Ranolazine—Vomiting—Vigabatrin—epilepsy syndrome	2.33e-05	0.000388	CcSEcCtD
Ranolazine—Skin disorder—Valproic Acid—epilepsy syndrome	2.33e-05	0.000388	CcSEcCtD
Ranolazine—Urinary tract disorder—Topiramate—epilepsy syndrome	2.33e-05	0.000387	CcSEcCtD
Ranolazine—Oedema peripheral—Topiramate—epilepsy syndrome	2.32e-05	0.000386	CcSEcCtD
Ranolazine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.32e-05	0.000386	CcSEcCtD
Ranolazine—Cough—Pregabalin—epilepsy syndrome	2.32e-05	0.000386	CcSEcCtD
Ranolazine—Pruritus—Phenytoin—epilepsy syndrome	2.32e-05	0.000385	CcSEcCtD
Ranolazine—Connective tissue disorder—Topiramate—epilepsy syndrome	2.32e-05	0.000385	CcSEcCtD
Ranolazine—Nausea—Levetiracetam—epilepsy syndrome	2.32e-05	0.000385	CcSEcCtD
Ranolazine—Rash—Vigabatrin—epilepsy syndrome	2.31e-05	0.000385	CcSEcCtD
Ranolazine—Dizziness—Felbamate—epilepsy syndrome	2.31e-05	0.000384	CcSEcCtD
Ranolazine—Dermatitis—Vigabatrin—epilepsy syndrome	2.31e-05	0.000384	CcSEcCtD
Ranolazine—Urethral disorder—Topiramate—epilepsy syndrome	2.31e-05	0.000384	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—DLG4—epilepsy syndrome	2.31e-05	0.000896	CbGpPWpGaD
Ranolazine—Pruritus—Oxcarbazepine—epilepsy syndrome	2.31e-05	0.000383	CcSEcCtD
Ranolazine—Vision blurred—Gabapentin—epilepsy syndrome	2.3e-05	0.000382	CcSEcCtD
Ranolazine—Headache—Vigabatrin—epilepsy syndrome	2.3e-05	0.000382	CcSEcCtD
Ranolazine—Vomiting—Diazepam—epilepsy syndrome	2.3e-05	0.000382	CcSEcCtD
Ranolazine—Anorexia—Valproic Acid—epilepsy syndrome	2.29e-05	0.000381	CcSEcCtD
Ranolazine—Tremor—Gabapentin—epilepsy syndrome	2.29e-05	0.00038	CcSEcCtD
Ranolazine—Rash—Diazepam—epilepsy syndrome	2.28e-05	0.000379	CcSEcCtD
Ranolazine—Dermatitis—Diazepam—epilepsy syndrome	2.28e-05	0.000378	CcSEcCtD
Ranolazine—Visual impairment—Topiramate—epilepsy syndrome	2.27e-05	0.000378	CcSEcCtD
Ranolazine—Dizziness—Zonisamide—epilepsy syndrome	2.26e-05	0.000376	CcSEcCtD
Ranolazine—Headache—Diazepam—epilepsy syndrome	2.26e-05	0.000376	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—GRIN2B—epilepsy syndrome	2.26e-05	0.000876	CbGpPWpGaD
Ranolazine—Anxiety—Pregabalin—epilepsy syndrome	2.26e-05	0.000375	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.25e-05	0.000374	CcSEcCtD
Ranolazine—Hypotension—Valproic Acid—epilepsy syndrome	2.24e-05	0.000373	CcSEcCtD
Ranolazine—Asthenia—Carbamazepine—epilepsy syndrome	2.24e-05	0.000373	CcSEcCtD
Ranolazine—Nausea—Fosphenytoin—epilepsy syndrome	2.24e-05	0.000372	CcSEcCtD
Ranolazine—Angioedema—Gabapentin—epilepsy syndrome	2.23e-05	0.000371	CcSEcCtD
Ranolazine—Vomiting—Felbamate—epilepsy syndrome	2.22e-05	0.00037	CcSEcCtD
Ranolazine—Dry mouth—Pregabalin—epilepsy syndrome	2.22e-05	0.000368	CcSEcCtD
Ranolazine—Pruritus—Carbamazepine—epilepsy syndrome	2.21e-05	0.000368	CcSEcCtD
Ranolazine—Rash—Felbamate—epilepsy syndrome	2.2e-05	0.000367	CcSEcCtD
Ranolazine—Eye disorder—Topiramate—epilepsy syndrome	2.2e-05	0.000366	CcSEcCtD
Ranolazine—Dermatitis—Felbamate—epilepsy syndrome	2.2e-05	0.000366	CcSEcCtD
Ranolazine—Tinnitus—Topiramate—epilepsy syndrome	2.2e-05	0.000365	CcSEcCtD
Ranolazine—Vertigo—Gabapentin—epilepsy syndrome	2.19e-05	0.000364	CcSEcCtD
Ranolazine—Headache—Felbamate—epilepsy syndrome	2.19e-05	0.000364	CcSEcCtD
Ranolazine—Confusional state—Pregabalin—epilepsy syndrome	2.19e-05	0.000364	CcSEcCtD
Ranolazine—Cardiac disorder—Topiramate—epilepsy syndrome	2.19e-05	0.000364	CcSEcCtD
Ranolazine—Syncope—Gabapentin—epilepsy syndrome	2.19e-05	0.000364	CcSEcCtD
Ranolazine—Leukopenia—Gabapentin—epilepsy syndrome	2.18e-05	0.000363	CcSEcCtD
Ranolazine—Dizziness—Clonazepam—epilepsy syndrome	2.18e-05	0.000363	CcSEcCtD
Ranolazine—Nausea—Vigabatrin—epilepsy syndrome	2.18e-05	0.000362	CcSEcCtD
Ranolazine—Vomiting—Zonisamide—epilepsy syndrome	2.18e-05	0.000362	CcSEcCtD
Ranolazine—Insomnia—Valproic Acid—epilepsy syndrome	2.17e-05	0.000361	CcSEcCtD
Ranolazine—Asthenia—Lamotrigine—epilepsy syndrome	2.17e-05	0.000361	CcSEcCtD
Ranolazine—Dizziness—Phenytoin—epilepsy syndrome	2.17e-05	0.00036	CcSEcCtD
Ranolazine—Rash—Zonisamide—epilepsy syndrome	2.16e-05	0.000359	CcSEcCtD
Ranolazine—Paraesthesia—Valproic Acid—epilepsy syndrome	2.16e-05	0.000359	CcSEcCtD
Ranolazine—Palpitations—Gabapentin—epilepsy syndrome	2.16e-05	0.000358	CcSEcCtD
Ranolazine—Dermatitis—Zonisamide—epilepsy syndrome	2.16e-05	0.000358	CcSEcCtD
Ranolazine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.16e-05	0.000358	CcSEcCtD
Ranolazine—Nausea—Diazepam—epilepsy syndrome	2.15e-05	0.000357	CcSEcCtD
Ranolazine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.14e-05	0.000356	CcSEcCtD
Ranolazine—Headache—Zonisamide—epilepsy syndrome	2.14e-05	0.000356	CcSEcCtD
Ranolazine—Dyspnoea—Valproic Acid—epilepsy syndrome	2.14e-05	0.000356	CcSEcCtD
Ranolazine—Angiopathy—Topiramate—epilepsy syndrome	2.14e-05	0.000356	CcSEcCtD
Ranolazine—Pruritus—Lamotrigine—epilepsy syndrome	2.14e-05	0.000356	CcSEcCtD
Ranolazine—Shock—Pregabalin—epilepsy syndrome	2.14e-05	0.000355	CcSEcCtD
Ranolazine—Somnolence—Valproic Acid—epilepsy syndrome	2.14e-05	0.000355	CcSEcCtD
Ranolazine—Nervous system disorder—Pregabalin—epilepsy syndrome	2.13e-05	0.000354	CcSEcCtD
Ranolazine—Cough—Gabapentin—epilepsy syndrome	2.13e-05	0.000354	CcSEcCtD
Ranolazine—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.13e-05	0.000353	CcSEcCtD
Ranolazine—Mediastinal disorder—Topiramate—epilepsy syndrome	2.13e-05	0.000353	CcSEcCtD
Ranolazine—Dyspepsia—Valproic Acid—epilepsy syndrome	2.11e-05	0.000351	CcSEcCtD
Ranolazine—Skin disorder—Pregabalin—epilepsy syndrome	2.11e-05	0.000351	CcSEcCtD
Ranolazine—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.1e-05	0.000349	CcSEcCtD
Ranolazine—Vomiting—Clonazepam—epilepsy syndrome	2.1e-05	0.000349	CcSEcCtD
Ranolazine—Decreased appetite—Valproic Acid—epilepsy syndrome	2.09e-05	0.000347	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—AKT3—epilepsy syndrome	2.09e-05	0.000809	CbGpPWpGaD
Ranolazine—Vomiting—Phenytoin—epilepsy syndrome	2.08e-05	0.000346	CcSEcCtD
Ranolazine—Rash—Clonazepam—epilepsy syndrome	2.08e-05	0.000346	CcSEcCtD
Ranolazine—Dermatitis—Clonazepam—epilepsy syndrome	2.08e-05	0.000345	CcSEcCtD
Ranolazine—Nausea—Felbamate—epilepsy syndrome	2.08e-05	0.000345	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.07e-05	0.000345	CcSEcCtD
Ranolazine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.07e-05	0.000344	CcSEcCtD
Ranolazine—Fatigue—Valproic Acid—epilepsy syndrome	2.07e-05	0.000344	CcSEcCtD
Ranolazine—Anxiety—Gabapentin—epilepsy syndrome	2.07e-05	0.000344	CcSEcCtD
Ranolazine—Anorexia—Pregabalin—epilepsy syndrome	2.07e-05	0.000344	CcSEcCtD
Ranolazine—Dizziness—Carbamazepine—epilepsy syndrome	2.07e-05	0.000344	CcSEcCtD
Ranolazine—Headache—Clonazepam—epilepsy syndrome	2.07e-05	0.000344	CcSEcCtD
Ranolazine—Rash—Phenytoin—epilepsy syndrome	2.07e-05	0.000343	CcSEcCtD
Ranolazine—Mental disorder—Topiramate—epilepsy syndrome	2.07e-05	0.000343	CcSEcCtD
Ranolazine—Dermatitis—Phenytoin—epilepsy syndrome	2.06e-05	0.000343	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.06e-05	0.000343	CcSEcCtD
Ranolazine—Rash—Oxcarbazepine—epilepsy syndrome	2.06e-05	0.000342	CcSEcCtD
Ranolazine—Constipation—Valproic Acid—epilepsy syndrome	2.05e-05	0.000341	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—TCF4—epilepsy syndrome	2.05e-05	0.000796	CbGpPWpGaD
Ranolazine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.05e-05	0.000341	CcSEcCtD
Ranolazine—Headache—Phenytoin—epilepsy syndrome	2.05e-05	0.000341	CcSEcCtD
Ranolazine—Malnutrition—Topiramate—epilepsy syndrome	2.05e-05	0.000341	CcSEcCtD
Ranolazine—Headache—Oxcarbazepine—epilepsy syndrome	2.04e-05	0.000339	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—ADAM10—epilepsy syndrome	2.04e-05	0.00079	CbGpPWpGaD
Ranolazine—Nausea—Zonisamide—epilepsy syndrome	2.03e-05	0.000338	CcSEcCtD
Ranolazine—Dry mouth—Gabapentin—epilepsy syndrome	2.03e-05	0.000338	CcSEcCtD
Ranolazine—Hypotension—Pregabalin—epilepsy syndrome	2.03e-05	0.000337	CcSEcCtD
Ranolazine—Flatulence—Topiramate—epilepsy syndrome	2.02e-05	0.000336	CcSEcCtD
Ranolazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	2.02e-05	0.000784	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—DLG4—epilepsy syndrome	2.02e-05	0.000783	CbGpPWpGaD
Ranolazine—Confusional state—Gabapentin—epilepsy syndrome	2.01e-05	0.000334	CcSEcCtD
Ranolazine—Dizziness—Lamotrigine—epilepsy syndrome	2e-05	0.000332	CcSEcCtD
Ranolazine—Vomiting—Carbamazepine—epilepsy syndrome	1.99e-05	0.000331	CcSEcCtD
Ranolazine—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.98e-05	0.000329	CcSEcCtD
Ranolazine—Muscle spasms—Topiramate—epilepsy syndrome	1.97e-05	0.000328	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—GRIN2B—epilepsy syndrome	1.97e-05	0.000765	CbGpPWpGaD
Ranolazine—Rash—Carbamazepine—epilepsy syndrome	1.97e-05	0.000328	CcSEcCtD
Ranolazine—Dermatitis—Carbamazepine—epilepsy syndrome	1.97e-05	0.000328	CcSEcCtD
Ranolazine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.96e-05	0.000327	CcSEcCtD
Ranolazine—Insomnia—Pregabalin—epilepsy syndrome	1.96e-05	0.000327	CcSEcCtD
Ranolazine—Nausea—Clonazepam—epilepsy syndrome	1.96e-05	0.000326	CcSEcCtD
Ranolazine—Headache—Carbamazepine—epilepsy syndrome	1.96e-05	0.000326	CcSEcCtD
Ranolazine—Shock—Gabapentin—epilepsy syndrome	1.96e-05	0.000326	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—KDR—epilepsy syndrome	1.96e-05	0.000759	CbGpPWpGaD
Ranolazine—Nervous system disorder—Gabapentin—epilepsy syndrome	1.95e-05	0.000325	CcSEcCtD
Ranolazine—Paraesthesia—Pregabalin—epilepsy syndrome	1.95e-05	0.000324	CcSEcCtD
Ranolazine—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.95e-05	0.000324	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—PRNP—epilepsy syndrome	1.95e-05	0.000755	CbGpPWpGaD
Ranolazine—Nausea—Phenytoin—epilepsy syndrome	1.95e-05	0.000324	CcSEcCtD
Ranolazine—Dyspnoea—Pregabalin—epilepsy syndrome	1.94e-05	0.000322	CcSEcCtD
Ranolazine—Nausea—Oxcarbazepine—epilepsy syndrome	1.94e-05	0.000322	CcSEcCtD
Ranolazine—Vision blurred—Topiramate—epilepsy syndrome	1.93e-05	0.000322	CcSEcCtD
Ranolazine—Skin disorder—Gabapentin—epilepsy syndrome	1.93e-05	0.000322	CcSEcCtD
Ranolazine—Somnolence—Pregabalin—epilepsy syndrome	1.93e-05	0.000321	CcSEcCtD
Ranolazine—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.93e-05	0.00032	CcSEcCtD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	1.92e-05	0.000746	CbGpPWpGaD
Ranolazine—Tremor—Topiramate—epilepsy syndrome	1.92e-05	0.00032	CcSEcCtD
Ranolazine—Vomiting—Lamotrigine—epilepsy syndrome	1.92e-05	0.000319	CcSEcCtD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	1.92e-05	0.000745	CbGpPWpGaD
Ranolazine—Urticaria—Valproic Acid—epilepsy syndrome	1.91e-05	0.000317	CcSEcCtD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	1.91e-05	0.00074	CbGpPWpGaD
Ranolazine—Rash—Lamotrigine—epilepsy syndrome	1.91e-05	0.000317	CcSEcCtD
Ranolazine—Dermatitis—Lamotrigine—epilepsy syndrome	1.9e-05	0.000317	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—CDC42—epilepsy syndrome	1.9e-05	0.000738	CbGpPWpGaD
Ranolazine—Abdominal pain—Valproic Acid—epilepsy syndrome	1.9e-05	0.000316	CcSEcCtD
Ranolazine—Anorexia—Gabapentin—epilepsy syndrome	1.9e-05	0.000316	CcSEcCtD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	1.9e-05	0.000735	CbGpPWpGaD
Ranolazine—Headache—Lamotrigine—epilepsy syndrome	1.89e-05	0.000315	CcSEcCtD
Ranolazine—Decreased appetite—Pregabalin—epilepsy syndrome	1.89e-05	0.000314	CcSEcCtD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	1.88e-05	0.00073	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—IL6ST—epilepsy syndrome	1.88e-05	0.000727	CbGpPWpGaD
Ranolazine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.87e-05	0.000312	CcSEcCtD
Ranolazine—Fatigue—Pregabalin—epilepsy syndrome	1.87e-05	0.000311	CcSEcCtD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	1.87e-05	0.000726	CbGpPWpGaD
Ranolazine—Hypotension—Gabapentin—epilepsy syndrome	1.86e-05	0.000309	CcSEcCtD
Ranolazine—Nausea—Carbamazepine—epilepsy syndrome	1.86e-05	0.000309	CcSEcCtD
Ranolazine—Constipation—Pregabalin—epilepsy syndrome	1.86e-05	0.000309	CcSEcCtD
Ranolazine—Vertigo—Topiramate—epilepsy syndrome	1.84e-05	0.000307	CcSEcCtD
Ranolazine—Syncope—Topiramate—epilepsy syndrome	1.84e-05	0.000306	CcSEcCtD
Ranolazine—Leukopenia—Topiramate—epilepsy syndrome	1.84e-05	0.000305	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—CDH2—epilepsy syndrome	1.83e-05	0.00071	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—SRC—epilepsy syndrome	1.82e-05	0.000707	CbGpPWpGaD
Ranolazine—Palpitations—Topiramate—epilepsy syndrome	1.81e-05	0.000302	CcSEcCtD
Ranolazine—Loss of consciousness—Topiramate—epilepsy syndrome	1.8e-05	0.0003	CcSEcCtD
Ranolazine—Insomnia—Gabapentin—epilepsy syndrome	1.8e-05	0.000299	CcSEcCtD
Ranolazine—Nausea—Lamotrigine—epilepsy syndrome	1.8e-05	0.000298	CcSEcCtD
Ranolazine—Cough—Topiramate—epilepsy syndrome	1.79e-05	0.000298	CcSEcCtD
Ranolazine—Feeling abnormal—Pregabalin—epilepsy syndrome	1.79e-05	0.000297	CcSEcCtD
Ranolazine—Paraesthesia—Gabapentin—epilepsy syndrome	1.79e-05	0.000297	CcSEcCtD
Ranolazine—Propranolol—CYP2C19—epilepsy syndrome	1.78e-05	0.0106	CrCbGaD
Ranolazine—SCN5A—Axon guidance—ADAM10—epilepsy syndrome	1.78e-05	0.00069	CbGpPWpGaD
Ranolazine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.78e-05	0.000295	CcSEcCtD
Ranolazine—Dyspnoea—Gabapentin—epilepsy syndrome	1.78e-05	0.000295	CcSEcCtD
Ranolazine—Somnolence—Gabapentin—epilepsy syndrome	1.77e-05	0.000294	CcSEcCtD
Ranolazine—Dyspepsia—Gabapentin—epilepsy syndrome	1.75e-05	0.000291	CcSEcCtD
Ranolazine—Anxiety—Topiramate—epilepsy syndrome	1.74e-05	0.00029	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—HES1—epilepsy syndrome	1.74e-05	0.000675	CbGpPWpGaD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.74e-05	0.000289	CcSEcCtD
Ranolazine—Carvedilol—CYP2D6—epilepsy syndrome	1.73e-05	0.0104	CrCbGaD
Ranolazine—Decreased appetite—Gabapentin—epilepsy syndrome	1.73e-05	0.000288	CcSEcCtD
Ranolazine—Urticaria—Pregabalin—epilepsy syndrome	1.73e-05	0.000287	CcSEcCtD
Ranolazine—Asthenia—Valproic Acid—epilepsy syndrome	1.72e-05	0.000286	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.72e-05	0.000286	CcSEcCtD
Ranolazine—Fatigue—Gabapentin—epilepsy syndrome	1.72e-05	0.000285	CcSEcCtD
Ranolazine—Abdominal pain—Pregabalin—epilepsy syndrome	1.72e-05	0.000285	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—ACTB—epilepsy syndrome	1.71e-05	0.000665	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	1.71e-05	0.000664	CbGpPWpGaD
Ranolazine—Dry mouth—Topiramate—epilepsy syndrome	1.71e-05	0.000284	CcSEcCtD
Ranolazine—Constipation—Gabapentin—epilepsy syndrome	1.7e-05	0.000283	CcSEcCtD
Ranolazine—Pruritus—Valproic Acid—epilepsy syndrome	1.7e-05	0.000283	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—FYN—epilepsy syndrome	1.69e-05	0.000657	CbGpPWpGaD
Ranolazine—Confusional state—Topiramate—epilepsy syndrome	1.69e-05	0.000281	CcSEcCtD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	1.69e-05	0.000655	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MEF2C—epilepsy syndrome	1.68e-05	0.000653	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ITGA2—epilepsy syndrome	1.68e-05	0.000653	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—CDC42—epilepsy syndrome	1.66e-05	0.000644	CbGpPWpGaD
Ranolazine—Shock—Topiramate—epilepsy syndrome	1.65e-05	0.000274	CcSEcCtD
Ranolazine—Nervous system disorder—Topiramate—epilepsy syndrome	1.64e-05	0.000273	CcSEcCtD
Ranolazine—Feeling abnormal—Gabapentin—epilepsy syndrome	1.64e-05	0.000273	CcSEcCtD
Ranolazine—Thrombocytopenia—Topiramate—epilepsy syndrome	1.64e-05	0.000273	CcSEcCtD
Ranolazine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.63e-05	0.000271	CcSEcCtD
Ranolazine—Skin disorder—Topiramate—epilepsy syndrome	1.63e-05	0.000271	CcSEcCtD
Ranolazine—Hyperhidrosis—Topiramate—epilepsy syndrome	1.62e-05	0.000269	CcSEcCtD
Ranolazine—Anorexia—Topiramate—epilepsy syndrome	1.6e-05	0.000265	CcSEcCtD
Ranolazine—Dizziness—Valproic Acid—epilepsy syndrome	1.59e-05	0.000264	CcSEcCtD
Ranolazine—Urticaria—Gabapentin—epilepsy syndrome	1.58e-05	0.000263	CcSEcCtD
Ranolazine—Abdominal pain—Gabapentin—epilepsy syndrome	1.57e-05	0.000262	CcSEcCtD
Ranolazine—Hypotension—Topiramate—epilepsy syndrome	1.57e-05	0.00026	CcSEcCtD
Ranolazine—Asthenia—Pregabalin—epilepsy syndrome	1.56e-05	0.000259	CcSEcCtD
Ranolazine—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	1.55e-05	0.000603	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	1.55e-05	0.0006	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	1.54e-05	0.000596	CbGpPWpGaD
Ranolazine—Pruritus—Pregabalin—epilepsy syndrome	1.54e-05	0.000255	CcSEcCtD
Ranolazine—Vomiting—Valproic Acid—epilepsy syndrome	1.53e-05	0.000254	CcSEcCtD
Ranolazine—Insomnia—Topiramate—epilepsy syndrome	1.52e-05	0.000252	CcSEcCtD
Ranolazine—Rash—Valproic Acid—epilepsy syndrome	1.51e-05	0.000252	CcSEcCtD
Ranolazine—Dermatitis—Valproic Acid—epilepsy syndrome	1.51e-05	0.000252	CcSEcCtD
Ranolazine—Headache—Valproic Acid—epilepsy syndrome	1.5e-05	0.00025	CcSEcCtD
Ranolazine—Paraesthesia—Topiramate—epilepsy syndrome	1.5e-05	0.00025	CcSEcCtD
Ranolazine—Dyspnoea—Topiramate—epilepsy syndrome	1.49e-05	0.000248	CcSEcCtD
Ranolazine—Somnolence—Topiramate—epilepsy syndrome	1.49e-05	0.000248	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—FYN—epilepsy syndrome	1.48e-05	0.000573	CbGpPWpGaD
Ranolazine—Dyspepsia—Topiramate—epilepsy syndrome	1.47e-05	0.000245	CcSEcCtD
Ranolazine—Decreased appetite—Topiramate—epilepsy syndrome	1.46e-05	0.000242	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.45e-05	0.00024	CcSEcCtD
Ranolazine—Fatigue—Topiramate—epilepsy syndrome	1.44e-05	0.00024	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—DLG4—epilepsy syndrome	1.44e-05	0.000558	CbGpPWpGaD
Ranolazine—Dizziness—Pregabalin—epilepsy syndrome	1.44e-05	0.000239	CcSEcCtD
Ranolazine—Constipation—Topiramate—epilepsy syndrome	1.43e-05	0.000238	CcSEcCtD
Ranolazine—Asthenia—Gabapentin—epilepsy syndrome	1.43e-05	0.000237	CcSEcCtD
Ranolazine—Nausea—Valproic Acid—epilepsy syndrome	1.43e-05	0.000237	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	1.42e-05	0.000552	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	1.42e-05	0.000551	CbGpPWpGaD
Ranolazine—Pruritus—Gabapentin—epilepsy syndrome	1.41e-05	0.000234	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—GRIN2B—epilepsy syndrome	1.41e-05	0.000546	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—KDR—epilepsy syndrome	1.4e-05	0.000541	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	1.39e-05	0.000538	CbGpPWpGaD
Ranolazine—Vomiting—Pregabalin—epilepsy syndrome	1.38e-05	0.00023	CcSEcCtD
Ranolazine—Feeling abnormal—Topiramate—epilepsy syndrome	1.38e-05	0.000229	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	1.38e-05	0.000535	CbGpPWpGaD
Ranolazine—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.37e-05	0.000228	CcSEcCtD
Ranolazine—Rash—Pregabalin—epilepsy syndrome	1.37e-05	0.000228	CcSEcCtD
Ranolazine—Dermatitis—Pregabalin—epilepsy syndrome	1.37e-05	0.000227	CcSEcCtD
Ranolazine—Headache—Pregabalin—epilepsy syndrome	1.36e-05	0.000226	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—IL6ST—epilepsy syndrome	1.34e-05	0.000519	CbGpPWpGaD
Ranolazine—Urticaria—Topiramate—epilepsy syndrome	1.33e-05	0.000221	CcSEcCtD
Ranolazine—Abdominal pain—Topiramate—epilepsy syndrome	1.32e-05	0.00022	CcSEcCtD
Ranolazine—Propranolol—CYP2D6—epilepsy syndrome	1.32e-05	0.00789	CrCbGaD
Ranolazine—Dizziness—Gabapentin—epilepsy syndrome	1.32e-05	0.000219	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—AKT3—epilepsy syndrome	1.3e-05	0.000504	CbGpPWpGaD
Ranolazine—Nausea—Pregabalin—epilepsy syndrome	1.29e-05	0.000214	CcSEcCtD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.28e-05	0.000497	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ADAM10—epilepsy syndrome	1.27e-05	0.000492	CbGpPWpGaD
Ranolazine—Vomiting—Gabapentin—epilepsy syndrome	1.27e-05	0.00021	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—CYP2C19—epilepsy syndrome	1.26e-05	0.000487	CbGpPWpGaD
Ranolazine—Rash—Gabapentin—epilepsy syndrome	1.26e-05	0.000209	CcSEcCtD
Ranolazine—Dermatitis—Gabapentin—epilepsy syndrome	1.25e-05	0.000209	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—CYP11A1—epilepsy syndrome	1.25e-05	0.000484	CbGpPWpGaD
Ranolazine—Headache—Gabapentin—epilepsy syndrome	1.25e-05	0.000207	CcSEcCtD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.24e-05	0.000481	CbGpPWpGaD
Ranolazine—Carvedilol—ABCB1—epilepsy syndrome	1.24e-05	0.00741	CrCbGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.23e-05	0.000478	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—KDR—epilepsy syndrome	1.22e-05	0.000473	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	1.2e-05	0.000467	CbGpPWpGaD
Ranolazine—Asthenia—Topiramate—epilepsy syndrome	1.2e-05	0.0002	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—MMP9—epilepsy syndrome	1.2e-05	0.000465	CbGpPWpGaD
Ranolazine—Pruritus—Topiramate—epilepsy syndrome	1.19e-05	0.000197	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—CDC42—epilepsy syndrome	1.19e-05	0.00046	CbGpPWpGaD
Ranolazine—Nausea—Gabapentin—epilepsy syndrome	1.18e-05	0.000197	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—IL6ST—epilepsy syndrome	1.17e-05	0.000453	CbGpPWpGaD
Ranolazine—Dizziness—Topiramate—epilepsy syndrome	1.11e-05	0.000184	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—SRC—epilepsy syndrome	1.11e-05	0.000429	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—HES1—epilepsy syndrome	1.09e-05	0.000421	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—FGF2—epilepsy syndrome	1.08e-05	0.00042	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—VEGFA—epilepsy syndrome	1.08e-05	0.000418	CbGpPWpGaD
Ranolazine—Vomiting—Topiramate—epilepsy syndrome	1.07e-05	0.000177	CcSEcCtD
Ranolazine—Rash—Topiramate—epilepsy syndrome	1.06e-05	0.000176	CcSEcCtD
Ranolazine—Dermatitis—Topiramate—epilepsy syndrome	1.06e-05	0.000175	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—FYN—epilepsy syndrome	1.06e-05	0.000409	CbGpPWpGaD
Ranolazine—Headache—Topiramate—epilepsy syndrome	1.05e-05	0.000174	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—MEF2C—epilepsy syndrome	1.05e-05	0.000407	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.04e-05	0.000403	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	1.03e-05	0.0004	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—RELA—epilepsy syndrome	1e-05	0.00039	CbGpPWpGaD
Ranolazine—Nausea—Topiramate—epilepsy syndrome	9.95e-06	0.000165	CcSEcCtD
Ranolazine—Propranolol—ABCB1—epilepsy syndrome	9.42e-06	0.00564	CrCbGaD
Ranolazine—SCN5A—Developmental Biology—KDR—epilepsy syndrome	8.7e-06	0.000337	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CA13—epilepsy syndrome	8.6e-06	0.000333	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MMP9—epilepsy syndrome	8.56e-06	0.000332	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	8.38e-06	0.000325	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6ST—epilepsy syndrome	8.34e-06	0.000323	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	8.22e-06	0.000319	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	8.17e-06	0.000317	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	8.1e-06	0.000314	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	8.05e-06	0.000312	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—SRC—epilepsy syndrome	7.9e-06	0.000306	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—VEGFA—epilepsy syndrome	7.69e-06	0.000298	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MMP9—epilepsy syndrome	7.48e-06	0.00029	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	7.37e-06	0.000286	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	7.27e-06	0.000282	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—SRC—epilepsy syndrome	6.89e-06	0.000267	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	6.8e-06	0.000264	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—FGF2—epilepsy syndrome	6.74e-06	0.000261	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—VEGFA—epilepsy syndrome	6.71e-06	0.00026	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TNF—epilepsy syndrome	6.59e-06	0.000256	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—FAR1—epilepsy syndrome	6.52e-06	0.000253	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PDXK—epilepsy syndrome	6.52e-06	0.000253	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CERS1—epilepsy syndrome	6.52e-06	0.000253	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADK—epilepsy syndrome	6.52e-06	0.000253	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	6.52e-06	0.000253	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	6.52e-06	0.000253	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RELA—epilepsy syndrome	6.26e-06	0.000243	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PNPO—epilepsy syndrome	5.96e-06	0.000231	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	5.96e-06	0.000231	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GAMT—epilepsy syndrome	5.96e-06	0.000231	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	5.96e-06	0.000231	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CA13—epilepsy syndrome	5.62e-06	0.000218	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—QDPR—epilepsy syndrome	5.54e-06	0.000215	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CA4—epilepsy syndrome	5.54e-06	0.000215	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	5.52e-06	0.000214	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP9—epilepsy syndrome	5.33e-06	0.000207	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—COX3—epilepsy syndrome	5.21e-06	0.000202	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	4.94e-06	0.000191	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	4.94e-06	0.000191	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PFKL—epilepsy syndrome	4.94e-06	0.000191	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	4.94e-06	0.000191	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	4.94e-06	0.000191	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—SRC—epilepsy syndrome	4.92e-06	0.000191	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—AKT1—epilepsy syndrome	4.91e-06	0.00019	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—VEGFA—epilepsy syndrome	4.79e-06	0.000186	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—UPB1—epilepsy syndrome	4.52e-06	0.000175	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ATIC—epilepsy syndrome	4.52e-06	0.000175	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NEU1—epilepsy syndrome	4.52e-06	0.000175	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	4.35e-06	0.000169	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADK—epilepsy syndrome	4.26e-06	0.000165	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	4.26e-06	0.000165	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	4.26e-06	0.000165	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	4.26e-06	0.000165	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	4.26e-06	0.000165	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	4.26e-06	0.000165	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	4.2e-06	0.000163	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	4.2e-06	0.000163	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TNF—epilepsy syndrome	4.11e-06	0.000159	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	3.95e-06	0.000153	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	3.9e-06	0.000151	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	3.9e-06	0.000151	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	3.9e-06	0.000151	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	3.9e-06	0.000151	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	3.84e-06	0.000149	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	3.74e-06	0.000145	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	3.74e-06	0.000145	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CA4—epilepsy syndrome	3.62e-06	0.00014	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	3.62e-06	0.00014	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	3.61e-06	0.00014	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	3.57e-06	0.000138	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	3.57e-06	0.000138	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	3.49e-06	0.000135	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	3.42e-06	0.000133	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.41e-06	0.000132	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	3.36e-06	0.00013	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	3.29e-06	0.000128	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.23e-06	0.000125	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.23e-06	0.000125	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.23e-06	0.000125	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.23e-06	0.000125	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.23e-06	0.000125	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	3.08e-06	0.00012	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—AKT1—epilepsy syndrome	3.06e-06	0.000119	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	2.99e-06	0.000116	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.95e-06	0.000115	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.95e-06	0.000115	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.95e-06	0.000115	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.84e-06	0.00011	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.74e-06	0.000106	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.74e-06	0.000106	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.71e-06	0.000105	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.71e-06	0.000105	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.58e-06	0.0001	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.51e-06	9.74e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.45e-06	9.49e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.45e-06	9.49e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.33e-06	9.05e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.33e-06	9.05e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.28e-06	8.86e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.24e-06	8.68e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.21e-06	8.55e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.19e-06	8.51e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.15e-06	8.35e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.15e-06	8.34e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.14e-06	8.28e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.01e-06	7.81e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.96e-06	7.59e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.84e-06	7.12e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.83e-06	7.09e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.77e-06	6.86e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.77e-06	6.86e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.74e-06	6.76e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.72e-06	6.69e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.72e-06	6.66e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.44e-06	5.59e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.43e-06	5.56e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.41e-06	5.49e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.41e-06	5.45e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.4e-06	5.42e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.38e-06	5.34e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.28e-06	4.96e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.26e-06	4.89e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.2e-06	4.65e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.19e-06	4.63e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.14e-06	4.42e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.13e-06	4.37e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.12e-06	4.36e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.12e-06	4.35e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.1e-06	4.26e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—POMC—epilepsy syndrome	9.44e-07	3.66e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.38e-07	3.64e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CAT—epilepsy syndrome	9.25e-07	3.59e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9e-07	3.49e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALB—epilepsy syndrome	8.61e-07	3.34e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.37e-07	3.24e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	7.53e-07	2.92e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.34e-07	2.84e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.19e-07	2.79e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.17e-07	2.39e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.63e-07	2.18e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.93e-07	1.91e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.79e-07	1.47e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.48e-07	9.6e-06	CbGpPWpGaD
